CDEK
← All drugs Report issue

triptorelin

Recombinant proteinexperimental

Clinical trial activity

6 trials · 12 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
4
Phase 3
2
Phase 4
0

Earliest trial started Nov 29, 2017 (NCT04650984)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 3 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Inorganic
No
Polymer
No
Multi-specific
No
Payload
TNF

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06683066Phase 1Dec 4, 2024Central Hospital, Zibo, Central South University, Chongqing Medical University, People's Hospital Of Yichang, Qingdao University, Shandong University, Shanxi Medical University, Sichuan University, Yuncheng Central Hospital
NCT05304663Phase 1Jun 1, 2022Philogen S.p.A.
NCT04443010Phase 1/Phase 2 (Phase 2)Dec 31, 2020Philogen S.p.A., University of Zurich
NCT04733183Phase 2Aug 28, 2020Philogen S.p.A.
NCT03567889Phase 3Jun 30, 2018Philogen S.p.A., University of South Florida
NCT04650984Phase 3Nov 29, 2017Philogen S.p.A.
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (12)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Philogen S.p.A.For profit5532017
Central Hospital, ZiboAcademic/Hospital1012024
Central South UniversityAcademic/Hospital1012024
Chongqing Medical UniversityAcademic/Hospital1012024
People's Hospital Of YichangAcademic/Hospital1012024
Qingdao UniversityAcademic/Hospital1112024
Shandong UniversityAcademic/Hospital1012024
Shanxi Medical UniversityAcademic/Hospital1012024
Sichuan UniversityAcademic/Hospital1012024
University of South FloridaAcademic/Hospital1012018
University of ZurichAcademic/Hospital1012020
Yuncheng Central HospitalAcademic/Hospital1012024
12 organizations
Page 1 / 1